2 results
Approved WMORecruiting
This study tests the ability of the Cue-shoe, a new cueing device, to provide patients with FoG with successful cueing.
Approved WMOCompleted
To assess and compare efficacy (complete response [CR] rate and overall survival [OS]) between SGI-110 and TC in adults with previously untreated AML who are not considered candidates for intensive remission induction chemotherapy.